Institutional survival following Norwood procedures is traditionally correlated with a center's surgical volume. Multiple single and multi-institutional studies conducted at large-volume centers have recently demonstrated improved survival following Norwood procedures. We report both short- and long-term outcomes at a single, small-volume institution and comment on factors potentially influencing outcomes at this institution.
Methods
All patients undergoing Norwood procedures from January 1, 2005, to January 1, 2020, at our institution were included in this study. Kaplan-Meier survival and Cox regression risk factor analyses were performed in addition to first interstage risk factor scoring to compare observed versus expected survival.
Results
The cohort included 113 patients. Kaplan-Meier freedom from death or transplant was 88%, 80%, and 76% at 1, 5, and 10 years, respectively. Freedom from death following hospital discharge after Norwood procedures was 94%, 87%, and 83% at 1, 5, and 10 years, respectively. The presence of genetic syndromes was a significant risk factor for mortality. First interstage observed-to-expected mortality following discharge was 0.57 (P = .04). Postoperative length of stay was comparable to that reported for the period 2015 to 2018 in the Society of Thoracic Surgeons Database.
Conclusions
Survival outcomes at this single, small-volume institution were similar to those reported by large-volume centers and multi-institutional collaborative studies. These results may be related to structural and functional features that have been demonstrated to influence outcomes in other studies. These factors are achievable by small-volume programs with sufficient resource allocation.
TweddellJSLitwinSBThomasJPJrMussattoK. Recent advances in the surgical management of the single ventricle pediatric patient. Pediatr Clin North Am. 1999;46(2):465-480, xii. doi:10.1016/s0031-3955(05)70129-2
2.
NorwoodWIKirklinJKSandersSP. Hypoplastic left heart syndrome: experience with palliative surgery. Am J Cardiol. 1980;45(1):87-91. doi:10.1016/0002-9149(80)90224-6
3.
OhyeRGSchranzDD’UdekemY. Current therapy for hypoplastic left heart syndrome and related single ventricle lesions. Circulation. 2016;134(17):1265-1279. doi:10.1161/CIRCULATIONAHA.116.022816
4.
FernandezFGShahianDMKormosR, et al.The society of thoracic surgeons national database 2019 annual report. Ann Thorac Surg.2019;108(6):1625-1632. doi:10.1016/j.athoracsur.2019.09.034
5.
HornikCPHeXJacobsJP, et al.Relative impact of surgeon and center volume on early mortality after the Norwood operation. Ann Thorac Surg. 2012;93(6):1992-1997. doi:10.1016/j.athoracsur.2012.01.107
6.
AndersonBRCiarleglioAJCohenDJ, et al.The Norwood operation: relative effects of surgeon and institutional volumes on outcomes and resource utilization. Cardiol Young. 2016;26(4):683-692. doi:10.1017/S1047951115001031
7.
AhmedHAndersonJBBatesKE, et al.Development of a validated risk score for interstage death or transplant after stage I palliation for single-ventricle heart disease. J Thorac Cardiovasc Surg. 2020;160(4):1021-1030. doi:10.1016/j.jtcvs.2019.11.001
8.
GaynorJWMahleWTCohenMI, et al.Risk factors for mortality after the Norwood procedure. Eur J Cardiothorac Surg. 2002;22(1):82-89. doi:10.1016/s1010-7940(02)00198-7
9.
MillerTAGhanayemNSNewburgerJW, et al.Gestational age, birth weight, and outcomes six years after the Norwood procedure. Pediatrics. 2019;143(5):e20182577. doi:10.1542/peds.2018-2577
10.
GhanayemNSAllenKRTabbuttS, et al.Interstage mortality after the Norwood procedure: results of the multicenter single ventricle reconstruction trial. J Thorac Cardiovasc Surg. 2012;144(4):896-906. doi:10.1016/j.jtcvs.2012.05.020
11.
DeanPNMcHughKEConawayMRHillmanDGGutgesellHP. Effects of race, ethnicity, and gender on surgical mortality in hypoplastic left heart syndrome. Pediatr Cardiol. 2013;34(8):1829-1836. doi:10.1007/s00246-013-0723-3
12.
HehirDADominguezTEBallwegJA, et al.Risk factors for interstage death after stage 1 reconstruction of hypoplastic left heart syndrome and variants. J Thorac Cardiovasc Surg. 2008;136(1):94-99. e993. doi:10.1016/j.jtcvs.2007.12.012.
13.
Sames-DolzerEHakamiLInnerhuberMTulzerGMairR. Older age at the time of the Norwood procedure is a risk factor for early postoperative mortality†. Eur J Cardiothorac Surg. 2015;47(2):257-261. doi:10.1093/ejcts/ezu128
14.
ShamszadPGospinTAHongBJMcKenzieEDPetitCJ. Impact of preoperative risk factors on outcomes after Norwood palliation for hypoplastic left heart syndrome. J Thorac Cardiovasc Surg. 2014;147(3):897-901. doi:10.1016/j.jtcvs.2013.05.012
15.
TanemJRuddNRauscherJScottAFrommeltMAHillGD. Survival after Norwood procedure in high-risk patients. Ann Thorac Surg. 2020;109(3):828-833. doi:10.1016/j.athoracsur.2019.07.070
16.
AltmannKPrintzBFSolowiejczkyDEGersonyWMQuaegebeurJApfelHD. Two-dimensional echocardiographic assessment of right ventricular function as a predictor of outcome in hypoplastic left heart syndrome. Am J Cardiol. 2000;86(9):964-968. doi:10.1016/s0002-9149(00)01131-0
17.
CarvajalHGCanterMWAbarbanellAMEghtesadyP. Does ascending aorta size affect Norwood outcomes in hypoplastic left heart with aortic atresia?Ann Thorac Surg. 2020;110(5):1651-1658. doi:10.1016/j.athoracsur.2020.02.037
18.
AlsoufiBMcCrackenCKochilasLKClabbyMKanterK. Factors associated with interstage mortality following neonatal single ventricle palliation. World J Pediatr Congenit Heart Surg. 2018;9(6):616-623. doi:10.1177/2150135118787723
19.
HillGDTanemJGhanayemN, et al.Selective use of inpatient interstage management after Norwood procedure. Ann Thorac Surg. 2020;109(1):139-147. doi:10.1016/j.athoracsur.2019.07.062
20.
MascioCEIronsMLIttenbachRF, et al.Thirty years and 1663 consecutive Norwood procedures: has survival plateaued?J Thorac Cardiovasc Surg. 2019;158(1):220-229. doi:10.1016/j.jtcvs.2018.12.117
21.
KaramlouTMezaJMNajmHKNigroJJHillKD. Single-ventricle reconstruction 2.0: a closer look at our understanding of care for infants undergoing the Norwood procedure. J Thorac Cardiovasc Surg. 2019;158(3):837-842. e5. doi:10.1016/j.jtcvs.2018.12.121.
22.
NewburgerJWSleeperLAGaynorJW, et al.Transplant-free survival and interventions at 6 years in the SVR trial. Circulation. 2018;137(21):2246-2253. doi:10.1161/CIRCULATIONAHA.117.029375
23.
WelkeKFO’BrienSMPetersonEDUngerleiderRMJacobsMLJacobsJP. The complex relationship between pediatric cardiac surgical case volumes and mortality rates in a national clinical database. J Thorac Cardiovasc Surg. 2009;137(5):1133-1140. doi:10.1016/j.jtcvs.2008.12.012
24.
GongCLSongAYHorakR, et al.Impact of confounding on cost, survival, and length-of-stay outcomes for neonates with hypoplastic left heart syndrome undergoing stage 1 palliation surgery. Pediatr Cardiol. 2020;41(5):996-1011. doi:10.1007/s00246-020-02348-5
25.
Society of Thoracic Surgeons Congenital Heart Surgery Public Reporting. Arnold Palmer Medical Center STS Public Reporting (January 2015 - December 2018) [online] Publicreporting.sts.org. Available at: https://publicreporting.sts.org/congenital/1184709057 [Accessed April 8, 2022].
26.
JacobsJPJacobsMLAustinEH3rd, et al.Quality measures for congenital and pediatric cardiac surgery. World J Pediatr Congenit Heart Surg. 2012;3(1):32-47. doi:10.1177/2150135111426732
27.
TworetzkyWMcElhinneyDBReddyVMBrookMMHanleyFLSilvermanNH. Improved surgical outcome after fetal diagnosis of hypoplastic left heart syndrome. Circulation. 2001;103(9):1269-1273. doi:10.1161/01.cir.103.9.1269
28.
WilderTJMcCrindleBWHickeyEJ, et al.Is a hybrid strategy a lower-risk alternative to stage 1 Norwood operation?J Thorac Cardiovasc Surg. 2017;153(1):163-172. e6. doi:10.1016/j.jtcvs.2016.08.021.
29.
PizarroCDavisDAHealyRMKerinsPJNorwoodWI. Is there a role for extracorporeal life support after stage I Norwood?Eur J Cardiothorac Surg. 2001;19(3):294-301. doi:10.1016/s1010-7940(01)00575-9
30.
ReinhardtZDe GiovanniJStickleyJ, et al.Catheter interventions in the staged management of hypoplastic left heart syndrome. Cardiol Young. 2014;24(2):212-219. doi:10.1017/S1047951113000024
31.
TwiteMDIngRJ. Anesthetic considerations in infants with hypoplastic left heart syndrome. Semin Cardiothorac Vasc Anesth. 2013;17(2):137-145. doi:10.1177/1089253213476958
32.
Anderson JB, Beekman RH 3rd, Kugler JD, et al. Improvement in interstage survival in a national pediatric cardiology learning network. Circ Cardiovasc Qual Outcomes. 2015;8(4):428-436. doi:10.1161/CIRCOUTCOMES.115.001956
33.
CostelloJMPrezeENguyenN, et al.Experience with an acuity adaptable care model for pediatric cardiac surgery. World J Pediatr Congenit Heart Surg. 2017;8(6):665-671. doi:10.1177/2150135117733722
34.
LambertLMPikeNAMedoff-CooperB, et al.Variation in feeding practices following the Norwood procedure. J Pediatr. 2014;164(2):237-242. e1. doi:10.1016/j.jpeds.2013.09.042.
35.
PourmoghadamKKDeCampliWMRuzmetovM, et al.Recurrent laryngeal nerve injury and swallowing dysfunction in neonatal aortic arch repair. Ann Thorac Surg. 2017;104(5):1611-1618. doi:10.1016/j.athoracsur.2017.03.080
36.
GhanayemNSHoffmanGMMussattoKA, et al.Home surveillance program prevents interstage mortality after the Norwood procedure. J Thorac Cardiovasc Surg. 2003;126(5):1367-1377. doi:10.1016/s0022-5223(03)00071-0
37.
Oster ME, Kelleman M, McCracken C, et al. Association of digoxin with interstage mortality: Results from the Pediatric Heart Network Single Ventricle Reconstruction trial public use dataset. J Am Heart Assoc. 2016;5(1):e002566. Published 2016 Jan 13. doi:10.1161/JAHA.115.002566
38.
AnagnostopoulosPV. Volume should not be used as the sole criterion in designing regionalization of care systems in Congenital Cardiac Surgery. Abstract presented at: Society of Thoracic Surgeons; January 30, 2022; Miami, Florida.
